Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The first echinocandin: caspofungin.
Cornely OA, Schmitz K, Aisenbrey S. Cornely OA, et al. Mycoses. 2002;45 Suppl 3:56-60. doi: 10.1111/j.1439-0507.2002.tb04771.x. Mycoses. 2002. PMID: 12690973 Review.
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
Glasmacher A, Cornely OA, Orlopp K, Reuter S, Blaschke S, Eichel M, Silling G, Simons B, Egerer G, Siemann M, Florek M, Schnitzler R, Ebeling P, Ritter J, Reinel H, Schütt P, Fischer H, Hahn C, Just-Nuebling G. Glasmacher A, et al. Among authors: cornely oa. J Antimicrob Chemother. 2006 Jan;57(1):127-34. doi: 10.1093/jac/dki410. Epub 2005 Nov 24. J Antimicrob Chemother. 2006. PMID: 16308418 Clinical Trial.
Second-line treatment in invasive mould infections.
Karthaus M, Cornely OA. Karthaus M, et al. Among authors: cornely oa. Mycoses. 2006;49 Suppl 1:23-6. doi: 10.1111/j.1439-0507.2006.01298.x. Mycoses. 2006. PMID: 16961578 Review.
Anidulafungin--state of affairs from a clinical perspective.
Vehreschild JJ, Kümmerle T, Karthaus M, Cornely OA. Vehreschild JJ, et al. Among authors: cornely oa. Mycoses. 2007;50 Suppl 1:38-43. doi: 10.1111/j.1439-0507.2007.01378.x. Mycoses. 2007. PMID: 17394608 Review.
Treatment options in candidaemia.
Karthaus M, Cornely OA. Karthaus M, et al. Among authors: cornely oa. Mycoses. 2007;50 Suppl 1:44-9. doi: 10.1111/j.1439-0507.2007.01379.x. Mycoses. 2007. PMID: 17394609 Review.
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group. Kuse ER, et al. Among authors: cornely oa. Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9. Lancet. 2007. PMID: 17482982 Clinical Trial.
Caspofungin for the treatment of less common forms of invasive candidiasis.
Cornely OA, Lasso M, Betts R, Klimko N, Vazquez J, Dobb G, Velez J, Williams-Diaz A, Lipka J, Taylor A, Sable C, Kartsonis N. Cornely OA, et al. J Antimicrob Chemother. 2007 Aug;60(2):363-9. doi: 10.1093/jac/dkm169. Epub 2007 May 26. J Antimicrob Chemother. 2007. PMID: 17526917
633 results